本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

和黃醫藥

14.68
+0.25001.73%
盤後14.680.00000.00%18:48 EDT
成交量:5.92萬
成交額:86.90萬
市值:25.61億
市盈率:5.54
高:14.82
開:14.58
低:14.53
收:14.43
52周最高:19.50
52周最低:11.51
股本:1.74億
流通股本:1.04億
量比:2.20
換手率:0.06%
股息:- -
股息率:- -
每股收益(TTM):2.65
每股收益(LYR):0.2205
淨資產收益率:46.90%
總資產收益率:-0.81%
市淨率:2.08
市盈率(LYR):66.56

資料載入中...

2025/05/27

SEC問詢函

Form CORRESP - Correspondence
2025/03/19

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/28

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/08/24

SEC問詢函

Form CORRESP - Correspondence
2023/02/28

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/07/25

SEC問詢函

CORRESP [Cover] - Correspondence
2022/06/08

SEC問詢函

CORRESP [Cover] - Correspondence
2022/03/03

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/07

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/16

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/07/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/30

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/13

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/03/04

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/04

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/07/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans